SWK
RMD icon

Stephen W. Kidder’s ResMed RMD Stock Holding History

Stephen W. Kidder’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-932
Closed -$224K – 79
2025
Q4 		$224K Hold
932
– – 0.06% 69
2025
Q3 		$255K Sell
932
-16
-2% -$4.37K 0.07% 68
2025
Q2 		$245K Buy
+948
New +$226K 0.07% 71
2025
Q1 		– Sell
-888
Closed -$203K – 72
2024
Q4 		$203K Buy
+888
New +$214K 0.06% 70

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stephen W. Kidder's RMD Position: Q1 2026 in Review

Stephen W. Kidder sold out of ResMed (RMD) in Q1 2026, closing a stake of 932 shares — an estimated $224K sold.

Stephen W. Kidder first reported a position in RMD in Q4 2024 and held it in 4 quarters. The position peaked at $255K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Stephen W. Kidder reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
  • Stephen W. Kidder sold 932 ResMed shares in Q1 2026, an estimated $224K.
  • Stephen W. Kidder first reported a position in ResMed in Q4 2024 and held it in 4 quarters.
  • Stephen W. Kidder's ResMed position peaked at $255K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Stephen W. Kidder's 13F filing for Q1 2026, filed 11 May 2026.